Ethnic disparities in patients with systemic lupus erythematosus
- PMID: 12967518
- DOI: 10.1007/s11926-003-0022-8
Ethnic disparities in patients with systemic lupus erythematosus
Abstract
Ethnic disparities in health care have been historically well documented, but their causes still remain poorly explained. In the US, ethnic minorities have a higher incidence and prevalence of systemic lupus erythematosus and also experience less favorable outcomes when compared with the Caucasian majority. These discrepancies can be explained, at least in part, by genetic-related ethnic factors; however, nongenetic factors emerging from differences in socioeconomic status and related individual social (poverty, limited access to quality health care) and cultural characteristics (inadequate health belief patterns, distrust in medical institutions) are also likely to contribute to these discrepancies. A comprehensive recognition of current unfavorable, but modifiable, circumstances will provide the framework to develop strategic approaches toward eliminating existent disparities in health, including those occurring in patients with systemic lupus erythematosus.
Similar articles
-
Work disability in Argentinian patients with systemic lupus erythematosus is prevalent and it is due to ethnic, socioeconomic and disease-related factors.Int J Rheum Dis. 2018 Nov;21(11):2019-2027. doi: 10.1111/1756-185X.13269. Epub 2018 Apr 2. Int J Rheum Dis. 2018. PMID: 29611343
-
Use of Quality Measures to Identify Disparities in Health Care for Systemic Lupus Erythematosus.Rheum Dis Clin North Am. 2020 Nov;46(4):623-638. doi: 10.1016/j.rdc.2020.07.003. Epub 2020 Sep 9. Rheum Dis Clin North Am. 2020. PMID: 32981640 Free PMC article. Review.
-
Disparities in lupus care and outcomes.Curr Opin Rheumatol. 2009 Mar;21(2):102-9. doi: 10.1097/BOR.0b013e328323daad. Curr Opin Rheumatol. 2009. PMID: 19339919 Free PMC article. Review.
-
Addressing health disparities as a function of ethnicity in systemic lupus erythematosus patients.Lupus. 2022 Dec;31(14):1691-1705. doi: 10.1177/09612033221122983. Epub 2022 Aug 29. Lupus. 2022. PMID: 36036891 Review.
-
Lupus in Hispanics: a matter of serious concern.Cleve Clin J Med. 2012 Dec;79(12):824-34. doi: 10.3949/ccjm.79a.12048. Cleve Clin J Med. 2012. PMID: 23208987 Review.
Cited by
-
Phase III/IV, Randomized, Fifty-Two-Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus.Arthritis Rheumatol. 2022 Jan;74(1):112-123. doi: 10.1002/art.41900. Epub 2021 Dec 9. Arthritis Rheumatol. 2022. PMID: 34164944 Free PMC article. Clinical Trial.
-
Suppressor of cytokine signalling 3 (SOCS3) expressed in podocytes attenuates glomerulonephritis and suppresses autoantibody production in an imiquimod-induced lupus model.Lupus Sci Med. 2021 May;8(1):e000426. doi: 10.1136/lupus-2020-000426. Lupus Sci Med. 2021. PMID: 34016718 Free PMC article.
-
Barriers and facilitators to medical care retention for pediatric systemic lupus erythematosus in South Africa: a qualitative study.Res Sq [Preprint]. 2024 Feb 28:rs.3.rs-3919073. doi: 10.21203/rs.3.rs-3919073/v1. Res Sq. 2024. Update in: Pediatr Rheumatol Online J. 2024 May 28;22(1):59. doi: 10.1186/s12969-024-00994-0. PMID: 38464004 Free PMC article. Updated. Preprint.
-
European genetic ancestry is associated with a decreased risk of lupus nephritis.Arthritis Rheum. 2012 Oct;64(10):3374-82. doi: 10.1002/art.34567. Arthritis Rheum. 2012. PMID: 23023776 Free PMC article.
-
Why can't we find a new treatment for SLE?J Autoimmun. 2009 May-Jun;32(3-4):223-30. doi: 10.1016/j.jaut.2009.02.006. Epub 2009 Mar 28. J Autoimmun. 2009. PMID: 19329279 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Medical